- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/08 - Antiepileptics; Anticonvulsants
Patent holdings for IPC class A61P 25/08
Total number of patents in this class: 2415
10-year publication summary
63
|
89
|
88
|
147
|
241
|
214
|
265
|
292
|
209
|
62
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
GW Research Limited | 402 |
171 |
Taisho Pharmaceutical Co., Ltd. | 844 |
46 |
Xenon Pharmaceuticals Inc. | 190 |
35 |
The Regents of the University of California | 18943 |
34 |
Zogenix International Limited | 77 |
33 |
Sage Therapeutics, Inc. | 312 |
30 |
Takeda Pharmaceutical Company Limited | 2961 |
29 |
Janssen Pharmaceutica N.V. | 3839 |
24 |
Hoffmann-La Roche Inc. | 3060 |
23 |
F. Hoffmann-La Roche AG | 7958 |
21 |
Institute of Materia Medica, Chinese Academy of Medical Sciences | 165 |
21 |
Katholieke Universiteit Leuven | 1035 |
20 |
Banyu Pharmaceutical Co., Ltd. | 107 |
18 |
Marinus Pharmaceuticals, Inc. | 52 |
17 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
16 |
Shionogi & Co., Ltd. | 914 |
16 |
Sumitomo Dainippon Pharma Co., Ltd. | 226 |
16 |
Eisai R&D Management Co., Ltd. | 1304 |
16 |
Praxis Precision Medicines, Inc. | 140 |
16 |
H. Lundbeck A/S | 1252 |
15 |
Other owners | 1798 |